AbCellera Biologics (ABCL) Common Equity (2020 - 2026)
AbCellera Biologics' Common Equity was $896.02 million in Q2 2026, down 11.0% from $1.01 billion a year earlier and down 4.5% from the prior quarter.
Powered by 
Analysis
AbCellera Biologics (ABCL) Common Equity (2020 - 2026) Analysis & Trends
At the end of FY2025, Common Equity at AbCellera Biologics came in at $966.9 million, down 8.4% from FY2024.
- Common Equity has now declined for three consecutive years, though with a five-year compound annual growth rate of 3.1% (FY2020 to FY2025).
- In earlier years, Common Equity was $1.06 billion in FY2024 (-8.4%), $1.15 billion in FY2023 (-6.6%), $1.23 billion in FY2022 (+20.2%) and $1.03 billion in FY2021 (+23.5%).
- The Q2 2026 figure marks the lowest quarterly Common Equity since Q4 2020.
- Compared with a year earlier, Common Equity has declined for 13 straight quarters, with an average decline of 9.3% over the last eight quarters.
- The best year-over-year quarter for Common Equity over five years was Q3 2021 (growth of 968.2%); the worst was Q2 2026 (a decline of 11.0%).
- Per Business Quant data, ABCL's Common Equity in the three quarters before Q2 2026 was $938.08 million (Q1 2026), $966.9 million (Q4 2025) and $964.04 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.54 Bn | 572.07 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 467.01 Bn | 440.17 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.16 Bn | 321.59 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 277.56 Bn | 233.43 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 258.23 Bn | 231.79 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 224.14 Bn | 179.54 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 187.30 Bn | 161.42 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.47 Bn | 110.41 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.31 Bn | 105.31 Bn | 2.84 Bn | 20.25 Bn |
| 10 | AbCellera Biologics | 3.89 Bn | 3.89 Bn | - | 896.02 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 896.02 Mn |
| Mar 31, 2026 | 938.08 Mn |
| Dec 31, 2025 | 966.90 Mn |
| Sep 30, 2025 | 964.04 Mn |
| Jun 30, 2025 | 1.01 Bn |
| Mar 31, 2025 | 1.02 Bn |
| Dec 31, 2024 | 1.06 Bn |
| Sep 30, 2024 | 1.08 Bn |
| Jun 30, 2024 | 1.11 Bn |
| Mar 31, 2024 | 1.13 Bn |
| Dec 31, 2023 | 1.15 Bn |
| Sep 30, 2023 | 1.18 Bn |
| Jun 30, 2023 | 1.19 Bn |
| Mar 31, 2023 | 1.21 Bn |
| Dec 31, 2022 | 1.23 Bn |
| Sep 30, 2022 | 1.25 Bn |
| Jun 30, 2022 | 1.21 Bn |
| Mar 31, 2022 | 1.21 Bn |
| Dec 31, 2021 | 1.03 Bn |
| Sep 30, 2021 | 953.40 Mn |
API Access
AbCellera Biologics Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=ABCL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "ABCL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=ABCL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();